Our purpose was to report the cancers arising during a familial ovarian cancer screening program and investigate the tumor's clonality and association with BRCA1 and BRCA2 mutations.
Departments of Obstetrics and Gynecology, Pediatrics and Medical Genetics, and Pathology and Laboratory Medicine, Cedars-Sinai Medical Center, Los Angeles, CA, USA.
